The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma
Wei Hua(Huashan Hospital), Liangfu Zhou(Fudan University), Bao‐Guo Xiao(Shanghai Medical College of Fudan University), Ping Zhong(Jinan University), Xiaofang Sheng(Fudan University), Bojie Yang(Fudan University), Jingsong Wu(Fudan University), Yiwei Chu(Fudan University), Ying Mao(Fudan University), Yu Yao(Qinghai University)
Cited by 38
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
|Cancer Letters|2020|586
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345